EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research
Deadline Date: 1 July 2018
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
The mission of JDRF is to find a cure for type 1 diabetes and its complications through the support of research. JDRF was founded in 1970 by parents of children with diabetes who were convinced that the disease could be cured. JDRF gives more money to diabetes research than any other non-profit, non-governmental health agency in the world.
Lilly has for more than 95 years been a worldwide leader in diabetes care. Based in Indianapolis, USA Lilly introduced the world's first commercial insulin in 1923 and remains at the forefront of pharmaceutical and delivery-device innovation to manage diabetes. Lilly Diabetes is Lilly's integrated and global business dedicated to providing personal solutions for everyday life for people who live with and treat diabetes.
Programme Research and Focus
EFSD, JDRF and Lilly have established a programme called EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research to encourage new projects aimed at advancing current knowledge in this domain. To achieve the goals and objectives of this Programme, EFSD, JDRF and Lilly invite applications by issuing this "Request for Applications" (RFA), which indicates the areas of research emphasis.
The general goals of the Programme are to:
This year the Programme would particularly welcome projects in the following areas:
Mechanism of Support and Review
Research will be supported through the award of grants, each of up to Euro 100,000. The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application. EFSD may, on advisement from the Review Committee, recommend an award in a different amount from that requested, but which is considered more appropriate for the proposed studies.
Applicants who have a funding requirement larger than that specified above are also invited to apply to this Programme, particularly if this relates to a clinical research project: in this case, the relevant financial requirements not exceeding €400,000 should be indicated and well justified in the budget section of the application form for special consideration by the review committee.
Studies forming part of a larger project will be considered for funding but this will need to be well justified in the application (see Review Considerations).
Applications for an EFSD/JDRF/Lilly grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work.
Applications will be subject to scientific review by a specialised and independent ad hoc committee. It is anticipated that applications will be received, reviewed and approved for funding by October 2018.
Prior to any final decision on funding, and in order to offer applicants the opportunity to benefit from the review process, EFSD reserves the right to request revision of applications in accordance with the recommendations of the Review Committee.
Research Grant Applications
Applications for research grants may be subjected to pre-review (or triage) procedures. In this event, any application rejected at pre-review will not be subject to a complete scientific review, and no feedback report will be provided to the applicant.
The deadline for receipt of research grant applications for funding this year is 1 July 2018.
All budgets are to be prepared in Euros. For countries in which the Euro is not the common currency, the exchange rate (between the Euro and the local currency in the country where the work is to be performed) used for calculating the Euro budget must be mentioned under "Budget Justification".
Due to a change in the EFSD application system, application will open soon on
All applications must be prepared on the official application form in the EFSD online application system and completed in strict accordance with the detailed instructions to be found there. Applications which do not comply with the instructions given in the application system will not be considered for review.
Please submit your application in the EFSD online application system before 12:00 midday (CET) on the deadline date 1 July 2018.
Completed applications will be evaluated in accordance with the criteria stated below for scientific/technical merit by an appropriate and independent scientific committee.
Review criteria are as follows:
Reporting Requirements and Approval of Funding
All investigators funded by this Programme are required to submit a scientific report at the end of the project period. For those projects where funding is distributed over a period of more than one year, interim progress reports will also be required. Such reports will be subject to assessment prior to the release of any further funds.
Investigators must provide EFSD with copies of papers accepted for publication, and must acknowledge the support of the Programme in all written material by use of the phrase: "supported by an EFSD/JDRF/Lilly research grant".
Applications for a grant renewal will be accepted on a competitive basis, with the same review process as described in this Announcement. Such applications will therefore be considered in the same fashion as all other new applications received for review and without any special priority.
|Application Deadline:||1 July 2018|
|Anticipated Award:||October 2018|
Enquiries should be directed to:
European Foundation for the Study of Diabetes
Rheindorfer Weg 3
Tel: +49 211 7584690